04-06-2018 07:53 AM CET - Health & Medicine

Global Prefilled Auto Injectors Market 2017: Industry Expected to Reach US$ 3,616 Mn by 2022-end

Press release from: Fact.MR

The global market discussion on prefilled auto injectors industry can be found in the latest study by Fact.MR, which has been freshly added to its massive collection of research database. The report is titled “Prefilled Auto Injectors Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022”, which works to enlighten the readers about the major factors prompting the growth of the concerned market. Apart from that, the research majorly focuses on prefilled auto injectors market’s competitive outlook by profiling major players functioning across the globe. As the report moves ahead, information regarding the prominent trends as well as opportunities in the key geographical segments have also been elaborated, thus enabling companies to be able to make region-specific strategies for gaining competitive lead. Some of the prime regions emphasized in the study include key regions.

Request for Sample Report- www.factmr.com/connectus/sample?flag=S&rep_id=169

The arrival of an array of cutting-edge biotech products coupled with the increasing preference for convenient injection of various therapeutic drugs is making a positive impact on the global market for prefilled auto-injectors. Demand for such injectors is anticipated to further escalate over the next couple of years. Self-inject procedures have become safer and convenient due to availability of advanced prefilled auto-injectors. Patient are increasingly putting their trust on prefilled auto-injector owing to the product’s efficiency and credibility. Moreover, ongoing advancements in technology is leading towards constant improvement in prefilled auto-injector functionalities and capabilities. In order to expand their application in new therapeutic areas, most device manufacturers are now emphasizing on further development of prefilled auto-injectors. The next prefilled auto-injectors are more accurate and reliable. Such leading-edge instruments are becoming widespread due to their functional superiority on conventional needles and syringes that can cause injuries. Patients with needle phobia are also rapidly shifting towards prefilled auto-injectors, as these instruments typically have a centric design that helps the patients to overcome the unwillingness associated with self-inject procedures. The aforementioned factors are projected to propel the sales of prefilled auto-injectors globally. According to the recent study conducted by Fact.MR, the global prefilled auto injectors market is set to ride at a double-digit CAGR during 2017 to 2022, to reach a valuation in excess of US$ 3,616 Mn.

North America Will Continue to Spearhead the Global Prefilled Auto-Injectors Market

In terms of revenue, North America is expected to dominate the global prefilled auto-injectors market over 2022. This is primarily owing to the rising number of patients who require drug administration on regular basis. Owing to the extreme convenience of administrating insulin, prefilled auto injectors are also gaining popularity among patients suffering from diabetes in the region. The prefilled auto injectors market in North America in expected to witness a strong growth over the forecast period. Meanwhile, robust development of the healthcare sector coupled with low cost of prefilled auto-injectors is proving to be instrumental for the growth of the market in Asia-Pacific excluding Japan (APEJ). Between 2017 and 2022, the region’s market is projected to increase at an impressive CAGR of 15.9%.

Based on indication, the anaphylaxis segment currently accounts for more than two-third revenue share of the market. The segment is estimated to reach a market valuation of over US$ 3,187 Mn towards the end of 2022, reflecting a strong CAGR. In addition, the segment is expected to growing at around US$ 320 Mn annually over the course of the assessment period.

Competition Tracking

Fact.MR’s report also profiled companies that are expected to remain active in the expansion of global prefilled auto injectors market through 2022, which include Becton, Dickinson and Company, Pfizer Inc., Mylan N.V., Antares Pharma, Inc., Amgen Inc., and Eli Lilly and Company.

Browse Full Report with TOC- www.factmr.com/report/169/prefilled-auto-injectors-market

Table of Content:

1. Global Prefilled Auto-Injectors Market - Executive Summary

2. Global Prefilled Auto-Injectors Market Overview
2.1. Introduction
2.1.1. Global Prefilled Auto-Injectors Market Taxonomy
2.1.2. Global Prefilled Auto-Injectors Market Definition
2.2. Global Prefilled Auto-Injectors Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Prefilled Auto-Injectors Market Y-o-Y Growth
2.3. Global Prefilled Auto-Injectors Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. List of Distributors
2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Prefilled Auto-Injectors Market Analysis and Forecast By Indication
3.1. Global Prefilled Auto-Injectors Market Size and Forecast By Indication, 2012-2022
3.1.1. Anaphylaxis Prefilled Auto-Injectors Market Size and Forecast, 2012-2022 Revenue (US$ Mn) Comparison, By Region Market Share Comparison, By Region Y-o-Y growth Comparison, By Region
3.1.2. Multiple Sclerosis Prefilled Auto-Injectors Market Size and Forecast, 2012-2022 Revenue (US$ Mn) Comparison, By Region Market Share Comparison, By Region Y-o-Y growth Comparison, By Region


Check Discount on This Report- www.factmr.com/connectus/sample?flag=D&rep_id=169

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: www.factmr.com/

This release was published on openPR.
News-ID: 1005413 • Views: 146
More releasesMore releases

You can edit or delete your press release here: